Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection (Q33618621)
scientific article
Language:
(P31) (Q13442814)
(P304) 10-21
(P433) 1-2
(P478) 32
(P577) Tuesday, January 1, 1991
(P1433) (Q23928727)
(P1476) "Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection" (language: en)
(P2093) R R Bartlett
M Dimitrijevic
T Mattar
T Zielinski
T Germann
E Rüde
G H Thoenes
C C Küchle
H U Schorlemmer
E Bremer
(P2860) (Q41509536)
(Q36096860)
(Q39657791)
(Q41737179)
(Q67653057)
(Q53738690)
(Q53910981)
(Q36441887)
(Q70554049)
(Q69868281)
(Q36346536)
(Q40100402)
(Q41741604)
(Q41944209)
(Q68274247)
(Q46123894)
(Q70036432)
(Q68185619)
(Q68482784)
(Q68091404)
(Q68833917)
(Q34164164)
(Q39508686)
(Q69452831)
(Q33695508)
(Q69470771)
(Q34303725)
(Q38350632)
(Q68798664)
(Q40293112)
(Q69460916)
(Q93524307)
(Q46221748)
(Q72107425)
(Q52829763)
(Q68833074)
(P13046) (Q7318358)
other details
description scientific article

External Links